PRESS RELEASE
Hyderabad 26th Oct 2009
Granules India Ltd., a leading manufacturer of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs), announced financial results for its fiscal year 2010 second quarter ended September 30, 2009. Granules posted revenue of Rs. 96.44 Cr. which is the highest revenue achieved in a quarter by the Company and a net profit of Rs. 6.07 Cr., reflecting an increase of 18.4% and 121.3% over the same period last year, respectively.
Quarter ended September 30th 2009
- Net Sales: Rs. 96.44 Cr, as compared to the same period over the previous year at Rs. 81.45 Cr. The increase is attributed to the Company's focus on international markets.
- Profit Before Tax (PBT): Rs. 7.42 Cr, as compared to the same period over the previous year at Rs. 3.54 Cr, an increase of 109%.
- Net Profit: Rs. 6.07 Cr, as compared to the same period over the previous year of Rs. 2.74 Cr, an increase of 121%.
- EPS: Basic EPS was Rs. 3.02 as compared to the same period over the previous year at Rs. 1.37, an increase of 120%.
The Company achieved a turnover of Rs. 114.55 Cr. on a consolidated basis and a net profit of Rs. 7.75 Cr. The consolidated accounts include a joint-venture and subsidiaries. |
0 comments:
Post a Comment